Ghrelin as a Potential Anti-Obesity Target
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1383-1395
Author(s):
Tamas L. Horvath, Tamara Castaneda, Mads Tang-Christensen, Uberto Pagotto and Matthias H. Tschop
The Insulin-sensitizing Role of the Fat Derived Hormone Adiponectin
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1411-1418
Author(s):
K. L. Heilbronn, R. S. Smith and E. Ravussin
Genes Involved in Hereditary Hearing Impairment
Journal:
Current Genomics
Volume:
4
Page:
379-415
Author(s):
B. Haack, M. Pfister, N. Blin and S. Kupka
Di / tri-Peptide Transporters as Drug Delivery Targets: Regulation of Transport Under Physiological and Patho-physiological Conditions
Journal:
Current Drug Targets
Volume:
4
Page:
373-388
Author(s):
C. U. Nielsen and B. Brodin
Carnitine Metabolism and Deficit - When Supplementation is Necessary?
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
211-219
Author(s):
A. Evangeliou and D. Vlassopoulos
The Pyruvate Dehydrogenase Complex as a Target for Gene Therapy
Journal:
Current Gene Therapy
Volume:
3
Page:
239-245
Author(s):
Peter W. Stacpoole, Renius Owen and Terence R. Flotte
Is Impaired Flow-Mediated Dilatation of the Brachial Artery a Cardiovascular Risk Factor?
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
107-109
Author(s):
Stefan Agewall
Endothelial Therapy of Atherosclerosis and its Risk Factors
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
111-121
Author(s):
Tobias Traupe, Jana Ortmann, Klaus Munter and Matthias Barton
Nitric Oxide-Mediated Endothelial Dysfunction - Is there Need to Treat?
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
123-133
Author(s):
C. P. Tiefenbacher and J. Kreuzer
Vulnerable Atherosclerotic Plaque: Clinical Implications
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
183-204
Author(s):
Jinho Shin, Jay E. Edelberg and Mun K. Hong